ClinicalTrials.govpublic full text
Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
hiv infections, injections, subcutaneous, interleukin-2, dose-response relationship, drug, drug therapy, combination, cd4 lymphocyte count, anti-hiv agents, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813434
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.